Close Menu

multiplex assays

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bristol-Myers Squibb and Meso Scale Discovery today announced a deal to develop assays for use in Alzheimer's disease research.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Privately held Quantiscientifics today said that BioDot will co-market and sell its A2 MicroArray System.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received a CLIA Certificate of Compliance for its Australian lab from the US centers for Medicare and Medicaid Services.

The purchase would provide Luminex access to a "highly complementary" portfolio of molecular diagnostic assays.

The funds will be used to support increased adoption of the firm's multiplex gene expression testing platform for translational medicine, pharmaceutical clinical development, and pathology laboratory diagnostics.

The test is SQI's second multiplexed assay cleared by the FDA to run on the SQIDworks platform.

By testing 1,000 individuals with lung cancer for driver mutations in 10 genes, members of the Lung Cancer Mutation Consortium are finding mutations to help physicians offer more targeted treatment and clinical trial options for those with the disease.

Life Tech has gained global distribution rights to the system, which is a compact multiplex analyzer that rapidly detects 50 different analytes simultaneously on a single sample.

Garvan Institute will evaluate HealthLinx's prostate cancer biomarkers under one deal, while CPC Clinical Research will liaise with the FDA for HealthLinx's OvPlex test under a separate agreement.

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.